Comparison of plasma and CSF biomarkers in predicting cognitive decline

Abstract Objectives Concentrations of amyloid‐β peptides (Aβ42/Aβ40) and neurofilament light (NfL) can be measured in plasma or cerebrospinal fluid (CSF) and are associated with Alzheimer’s disease brain pathology and cognitive impairment. This study directly compared plasma and CSF measures of Aβ42...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Andrew J. Aschenbrenner, Yan Li, Rachel L. Henson, Katherine Volluz, Jason Hassenstab, Philip Verghese, Tim West, Matthew R. Meyer, Kristopher M. Kirmess, Anne M. Fagan, Chengjie Xiong, David Holtzman, John C. Morris, Randall J. Bateman, Suzanne E. Schindler
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2022-11-01
Serija:	Annals of Clinical and Translational Neurology
Online dostop:	https://doi.org/10.1002/acn3.51670
Oznake:	Označite Brez oznak, prvi označite!